SAN FRANCISCO, CA -- (Marketwired) -- 12/11/13 -- Kindred Biosciences, Inc. (Kindred Bio), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing of its initial public offering of 7,500,000 shares of its common stock at an initial public offering ...
↧